Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
about
Epigenetic silencing of DSC3 is a common event in human breast cancer.ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in gliomaLocal regulation of human breast xenograft models.Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone.Down regulation of ADAM33 as a Predictive Biomarker of Aggressive Breast CancerGenetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer.Epigenomics in cancer management.Epigenetic mechanisms of breast cancer: an update of the current knowledge.Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages.Resveratrol-salicylate derivatives as selective DNMT3 inhibitors and anticancer agents.Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signals.The expression of ADAM23 and its correlation with promoter methylation in non-small-cell lung carcinoma.Multiple mechanisms influence regulation of the cystic fibrosis transmembrane conductance regulator gene promoter.Decreased methylation in the SNAI2 and ADAM23 genes associated with de-differentiation and haematogenous dissemination in breast cancers
P2860
Q21195245-EDB0EE14-8C75-40E4-8FFF-512537558AFFQ31148772-8330DAB3-1AE3-452F-BDFE-9029DA1CFA96Q33415710-8142E38F-C879-4198-8971-A76E8D2C0ABAQ33739749-9D6FE0DE-3C23-4B2D-89DF-64C8099D29CDQ33964451-C0E94614-6B27-49CE-AB2B-BC381D69C86BQ34722504-5B912792-A009-43E5-AC0B-C0BE045BF6F6Q35739519-C2555826-18C7-476D-9A8B-7B27402B520AQ37704788-9AD4BD41-FC1B-44AB-95A4-C9AE628A2FE2Q37709387-0876C5F8-65C8-4CF7-92CD-0923B1B7701FQ37824255-C4833AEB-4277-47AC-9290-D339FF9C8445Q38296760-F3F7176E-B7F2-438C-A7F2-50E56E789C0AQ38758852-4789F62B-5663-4E0B-B898-E9F1CEE5922CQ38859365-59310998-1DA4-4459-95C8-84D92C910C3DQ39012270-54798853-0391-49DF-B390-B11019C2FA30Q39572038-47EFEC14-7997-459C-862C-AB8FABC1451AQ41864684-F5FDC50F-C1EA-4791-9EAE-E7144D980E21Q58761810-EFA8B167-03AB-4198-9DD4-E8E555AF2947
P2860
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
@ast
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
@en
type
label
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
@ast
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
@en
prefLabel
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
@ast
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
@en
P2093
P2860
P50
P356
P1433
P1476
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
@en
P2093
Alan Mackay
Andrew J G Simpson
Anna Christina M Salim
Daniela F Ierardi
Fabrício F Costa
Lilian C Pires
Mari C Sogayar
Michael O'Hare
Regina M Sasahara
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207263
P407
P577
2004-02-01T00:00:00Z
P5875
P6179
1007151627